Abstract
The role of a clinical microbiology laboratory is to provide meaningful results to the health care provider. The precision of such results depends on the testing method capabilities and the reporting protocols implemented by the laboratory. For mycobacteriology laboratories that have the capability to detect, isolate, and identify nontuberculous mycobacteria (NTM), species-level identification is the goal; however, definitive species identification may not be always achievable depending on the test method used or the NTM present. As a result, there can be inconsistencies in how results are reported by various laboratories, which may create confusion for the health care provider. In this letter, we attempt to provide a practical consensus on how to report these NTM and define terms associated with the major clinically significant NTM including the recommendation of discontinuation of the collective term “group” and use of the term “complex” or determination of the species. In addition, we provide a list of the most common species and subspecies currently recognized and validly published as comprising these NTM collectives, as well as selected non-validly published taxa of clinical significance.

This publication has 14 references indexed in Scilit: